Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mugwort pollen allergens are a complex mixture of proteins derived from the pollen of **Artemisia vulgaris** (mugwort), a weed from the family *Asteraceae* (Compositae)[1][3]. The major clinically relevant molecules are **Art v 1** (defensin-like protein) and **Art v 3** (non-specific lipid transfer protein), among others (Art v 2, Art v 4, Art v 5, Art v 6)[1][2]. These proteins are recognized by IgE antibodies in genetically predisposed individuals and trigger type I hypersensitivity reactions, causing symptoms such as allergic rhinitis, conjunctivitis, asthma, and sometimes systemic reactions (pollen allergy and pollen-food allergy syndrome)[1][2][3]. Pollen-derived allergens exhibit extensive cross-reactivity with other members of the *Asteraceae* family (e.g., ragweed), and can cause food allergies due to structurally similar allergens in foods (e.g. celery, peach, mustard)[1][2]. The dominant protein responsible for respiratory symptoms is Art v 1, while Art v 3 is significant for cross-reactive food allergy syndromes[1][2]. Mugwort pollen is not a single therapeutic target, but a source of multiple functionally unrelated protein allergens, and "allergens from mugwort pollen" is a category, not a molecule.
Drugs used for allergy block IgE binding to allergens, dampen allergic inflammation, or desensitize the immune system to allergens (immunotherapy)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mugwort pollen allergen (Art v (component name, e.g., Art v 1, Art v 3)).